|
|
 |
| Research Article |
|
| Involvement of chemokine receptors in breast cancer metastasis |
Mueller A. et al.
doi:10.1038/35065016
|
| Nature 1998 Mar;410(11):50—56. |
|
|
Abstract |
Full Text |
PDF |
|
 |
|
| Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. |
Mazumdar A et al.
doi:10.1038/35050532
|
| Nature Cell Biol. 2001 Jan;3(1):30—37. |
|
|
Abstract | Full Text |
PDF |
|
|
|
| The mammary gland iodide transporter is expressed during lactation and in breast cancer. |
Tazebay UH et al.
doi:10.1038/78630
|
| Nat Med. 2000 Aug;6(8):871—878. |
|
|
Abstract |
Full Text |
PDF |
|
|
|
| Compromised HOXA5 function can limit p53 expression in human breast tumours. |
Raman V et al.
doi:10.1038/35016125
|
| Nature 2000 Jun;405(6):974—978. |
|
|
Abstract |
Full Text |
PDF |
|
|
|
| Molecular portraits of human breast tumours. |
Perou CM et al.
doi:10.1038/35021093
|
| Nature 2000 ;406:747-752. |
|
|
Abstract |
Full Text |
PDF |
|
|
|
| The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. |
Coopman PJ et al.
doi:10.1038/35021086
|
| Nature 2000 ;406:742—747. |
|
|
Abstract |
Full |
PDF |
|
|
|
| Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. |
Li S et al.
doi:10.1038/35018134 |
| Nature 2000 ;406:210—215. |
|
|
Abstract |
Full Text |
PDF |
|
|
|
| High constant incidence in twins and other relatives of women with breast cancer. |
Peto J et al.
doi:10.1038/82533 |
| Nature Genet. 2000 Dec;26(4):411—414. |
|
|
Abstract |
Full Text |
PDF |
|
|
|
| Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study. |
Huttley GA et al.
doi:10.1038/78092 |
| Nature Genet. 2000 Jan;25(4):410—413. |
|
|
Abstract |
Full Text |
PDF |
|
|
|
| A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. |
Healey CS et al.
doi:10.1038/81691 |
| Nature Genet. 2000 Nov;216(3):362—364. |
|
|
Abstract |
Full Text |
PDF |
|
|
|
| Senescence bypass screen identifies TBX2, which represses cdkn2a (p19ARF) and is amplified in a subset of human breast cancers. |
Jacobs JJ et al.
doi:10.1038/81583 |
| Nature Genet. 2000 Nov;26(3):291—299. |
|
|
Abstract |
Full Text |
PDF |
|
|
|
| Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. |
Albertson DG et al.
doi:10.1038/75985 |
| Nature Genet. 2000 Jun;25(2):144—146. |
|
|
Abstract |
Full Text |
PDF |
|
|
|
